The United States is grappling with its largest measles outbreak in more than three decades, presenting new challenges for healthcare providers as they manage cases and complications rarely seen since the disease was declared eliminated in the country in 2000. The resurgence has forced medical professionals to revisit diagnosis and treatment protocols for a disease many have little recent experience with.

In Pennsylvania, where the outbreak is particularly severe, infectious disease specialist John Goldman has treated about 50 measles patients over the past year, encountering severe cases involving adults with pneumonia, pregnant women, and infants born with the infection. “There is a tremendous amount of what I would describe as learning on the fly,” Goldman said, highlighting the need for renewed medical vigilance.

The state’s outbreak has surpassed 1,500 cases and included at least eight deaths, centering heavily in the Plain community—comprising Amish and conservative Mennonite populations—where vaccination rates have historically been low. Many community members do not routinely engage with preventive healthcare, contributing to susceptibility despite the disease's disappearance nationally for decades.

The Centers for Disease Control and Prevention (CDC) reported over 5,400 measles cases nationwide this year, more than double the total from 2025. Notably, 41% of the cases involve adults aged 20 and older, up from 29% the previous year, indicating a shift from the disease’s historic pattern of primarily affecting children. The increase in adult infections is attributed to a cohort of unvaccinated individuals who neither contracted measles as children nor have immunity. In Pennsylvania, adults constitute approximately two-thirds of cases, some patients aged as high as 60.

Measles in adults often leads to more severe illness. Goldman cited examples including a patient requiring ventilator support for pneumonia and another hospitalized with sepsis before the characteristic rash appeared. Physicians emphasize the importance of recognizing early measles symptoms such as fever, cough, conjunctivitis, and facial rash, especially in the context of ongoing outbreaks in underimmunized populations.

The reemergence of measles has also raised concerns about pregnant women contracting the disease, a serious development not commonly encountered in recent decades. Measles during pregnancy heightens risks of pneumonia, miscarriage, stillbirth, and premature delivery, according to Kevin Ault, an obstetrician-gynecologist at Penn State Health. Pennsylvania health officials have issued a statewide alert regarding rising measles cases among pregnant women, urging immediate reporting and vaccination prior to pregnancy, as the measles, mumps, and rubella (MMR) vaccine is contraindicated during pregnancy.

Among the growing number of pregnant women infected—at least 101 in Pennsylvania since April—doctors report instances of congenital measles, where infants are born infected or acquire measles shortly after birth. Historical data suggest about 30% of babies born to infected mothers develop congenital measles, a figure consistent with recent observations. However, modern diagnostic advances may reveal additional complications not previously documented.

Long-term outcomes for infants born with or infected by measles shortly after birth remain uncertain. Physicians caution about potential developmental delays and the rare but fatal brain disorder subacute sclerosing panencephalitis (SSPE), which can arise years after acute measles infection. Neonatologists stress the importance of close follow-up but acknowledge limited information to guide prognosis due to the rarity of congenital measles in modern medical literature.

Underlying the outbreak’s severity is a combination of waning community immunity—resulting from declining vaccination rates—and pockets of populations with limited healthcare access. Public health experts continue to advocate for robust vaccination efforts to curb transmission and prevent further severe cases, especially among vulnerable groups like infants and pregnant women.

The U.S. formally lost its measles elimination status this week, reflecting continuous community transmission over the past year, as confirmed by the Pan American Health Organization. For clinicians confronting this evolving situation, the focus remains on rapid identification, vaccination outreach, and managing the complex clinical presentations emerging in this unprecedented resurgence.